The scheme seeks to provide capital appreciation by investing in a portfolio of Large and Midcap companies.
The scheme seeks to provide the investor with the opportunity of long-term capital appreciation by investing in diversified portfolio comprising predominantly large cap and mid cap companies.
7.9% of the combined portfolio weight is common between Quant Large and Mid Cap Fund Direct-Growth and SBI Large & Midcap Fund Direct Plan-Growth.
7 stocks appear in both portfolios.
The largest shared holding is Aurobindo Pharma Ltd., at 9.04% of Quant Large and Mid Cap Fund Direct-Growth and 2.07% of SBI Large & Midcap Fund Direct Plan-Growth.
The two funds hold largely different portfolios, so holding both can genuinely diversify your equity exposure.
Largest common holdings
Aurobindo Pharma Ltd.Adani Enterprises Ltd.Samvardhana Motherson International Ltd.HDFC Life Insurance Co Ltd.Hexaware Technologies Ltd.Reserve Bank of IndiaReserve Bank of India
Quant Large and Mid Cap Fund Direct-Growth has delivered the higher 3-year CAGR (17.60% vs 15.69%). SBI Large & Midcap Fund Direct Plan-Growth is the cheaper of the two with an expense ratio of 0.82% against 1.24%. SBI Large & Midcap Fund Direct Plan-Growth manages the larger corpus at ₹40.85k Cr. There is no single "better" fund — the right choice depends on your holding period, risk appetite and what you already own. Use the returns, risk and portfolio overlap tables above to judge which fits your portfolio, and remember that past returns do not guarantee future performance.
Over 1 year, Quant Large and Mid Cap Fund Direct-Growth returned 12.54% against 9.81% for SBI Large & Midcap Fund Direct Plan-Growth; and over 3 years, Quant Large and Mid Cap Fund Direct-Growth leads with a 17.60% CAGR versus 15.69%. Returns beyond one year are CAGR (annualised). Short-period returns are heavily influenced by market cycles, so compare over at least three to five years before drawing conclusions.
SBI Large & Midcap Fund Direct Plan-Growth has the lower expense ratio at 0.82%, compared with 1.24% for Quant Large and Mid Cap Fund Direct-Growth — a difference of 0.42% a year. The expense ratio is deducted from NAV daily, so a lower ratio directly improves your net return, though it should not be the only reason to pick a fund.
Both Quant Large and Mid Cap Fund Direct-Growth and SBI Large & Midcap Fund Direct Plan-Growth carry a "Very High" rating on the SEBI Riskometer. Within the same riskometer band, differences still show up in maximum drawdown, volatility and market-cap mix — all of which are compared in the tables above.
The portfolio overlap between the two funds is 7.9%, which is considered low. At this level the two funds hold largely different portfolios, so holding both can genuinely diversify your equity exposure. You can see the shared stocks in the overlap section above.
Yes — both are Equity: Large & MidCap funds, which means they follow similar mandates and are benchmarked against comparable indices. That makes a direct comparison of returns, expense ratio and risk meaningful.
Quant Large and Mid Cap Fund Direct-Growth has a NAV of ₹140.04 and an AUM of ₹3.45k Cr, and was launched on 31 Dec 2012. SBI Large & Midcap Fund Direct Plan-Growth has a NAV of ₹726.73 and an AUM of ₹40.85k Cr, launched on 31 Dec 2012. NAV on its own says nothing about how expensive or cheap a fund is — only the return on it matters.
